Noben capsules 30mg, No. 30

psychoorganic syndrome caused by cerebral circulation disorders and age-related involutional changes in the brain;

cerebroasthenic disorders of vascular, traumatic, psychogenic (neurasthenia) and combined etiology, manifested in the form of: memory and / or attention disorders, decreased intellectual productivity and general activity, emotional instability, asthenic, asthenic-depressive and moderate depressive conditions, headache, dizziness , tinnitus.

Inside, after eating. 1 caps. (30 mg) 2-3 times a day, it is recommended to make an evening reception no later than 17 hours. The duration of the course of therapy is 1.5-2 months. It is recommended to repeat courses 2-3 times a year.

Capsules

In 1 capsule

idebenone 30 mg

Excipients:

lactose monohydrate - 102 mg; MCC 20 mg; potato starch - 39.4 mg; povidone (low molecular weight medical polyvinylpyrrolidone or plasdone) - 8 mg; magnesium stearate - 0.6 mg capsule shell: titanium dioxide - 1.3333%; quinoline yellow - 0.9197%; 'Sunset in the sun' yellow - 0.0044%; gelatin - up to 100%

hypersensitivity to the active ingredient idebenone;

chronic renal failure;

children under 18 years of age (due to lack of data).

With caution: should be used during pregnancy and lactation.

pharmachologic effect

Nootropic agent, has a metabolic effect. Increases metabolic processes in the brain by activating the synthesis of glucose and ATP, improves blood supply and oxygenation of brain tissues, promotes the elimination of lactates; increases the intensity and speed of neurophysiological reactions of brain structures. By slowing down lipid peroxidation, it protects the membranes of neurons and mitochondria from damage.

From the first days of admission, an antiasthenic, psychostimulating and antidepressant effect is manifested, a nootropic effect manifests itself after 3-4 weeks. reception.

Indications of active substances of NobenЃ

Psychoorganic syndrome against the background of cerebrovascular accident and age-related involutional changes in the brain; cerebroasthenic disorders of vascular, traumatic, psychogenic (neurasthenia) etiology: impaired memory and / or attention, decreased intellectual productivity and general activity, emotional instability; asthenic and astheno-depressive syndrome, moderate depressive syndrome; dizziness, tinnitus.

Dosage regimen

Inside - 30 mg 2-3 times / day after meals, the last intake - up to 17 hours. The course of treatment - 1.5-2 months; if necessary - carry out 2-3 courses per year. Side effect From the side of the central nervous system: sleep disturbance, mental agitation, headache.

Others: dyspepsia, allergic reactions.

Contraindications for use

Chronic renal failure, hypersensitivity to the active substance.

Application during pregnancy and lactation

Use with caution during pregnancy and lactation.

Application for impaired renal function

Contraindicated in chronic renal failure.

special instructions

Influence on the ability to drive vehicles and use mechanisms

Not to be used by transport drivers and patients whose profession requires a high concentration of attention and speed of psychomotor reactions.